vs
Cytek Biosciences, Inc.（CTKB）与Star Equity Holdings, Inc.（STRR）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Star Equity Holdings, Inc.的1.1倍（$62.1M vs $56.8M），Star Equity Holdings, Inc.净利率更高（-3.0% vs -70.9%，领先67.9%），Star Equity Holdings, Inc.同比增速更快（69.0% vs 8.1%），Cytek Biosciences, Inc.自由现金流更多（$-1.8M vs $-9.0M），过去两年Star Equity Holdings, Inc.的营收复合增速更高（29.5% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
该公司信息存在混淆，Stars Equity Holdings, Inc.为一家投资控股企业，而描述提及的Artists Equity是由本·阿弗莱克和马特·达蒙两位演员兼制片人于2022年11月创立的美国制片公司。
CTKB vs STRR — 直观对比
营收规模更大
CTKB
是对方的1.1倍
$56.8M
营收增速更快
STRR
高出60.9%
8.1%
净利率更高
STRR
高出67.9%
-70.9%
自由现金流更多
CTKB
多$7.2M
$-9.0M
两年增速更快
STRR
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $56.8M |
| 净利润 | $-44.1M | $-1.7M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | -0.2% |
| 净利率 | -70.9% | -3.0% |
| 营收同比 | 8.1% | 69.0% |
| 净利润同比 | -557.1% | -192.1% |
| 每股收益（稀释后） | — | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBSTRR
| Q4 25 | $62.1M | $56.8M | ||
| Q3 25 | $52.3M | $48.0M | ||
| Q2 25 | $45.6M | $35.5M | ||
| Q1 25 | $41.5M | $31.9M | ||
| Q4 24 | $57.5M | $33.6M | ||
| Q3 24 | $51.5M | $36.9M | ||
| Q2 24 | $46.6M | $35.7M | ||
| Q1 24 | $44.9M | $33.9M |
净利润CTKBSTRR
| Q4 25 | $-44.1M | $-1.7M | ||
| Q3 25 | $-5.5M | $-1.8M | ||
| Q2 25 | $-5.6M | $-688.0K | ||
| Q1 25 | $-11.4M | $-1.8M | ||
| Q4 24 | $9.6M | $-585.0K | ||
| Q3 24 | $941.0K | $-846.0K | ||
| Q2 24 | $-10.4M | $-441.0K | ||
| Q1 24 | $-6.2M | $-2.9M |
毛利率CTKBSTRR
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | 43.0% | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | 50.5% | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBSTRR
| Q4 25 | -9.0% | -0.2% | ||
| Q3 25 | -17.6% | -3.4% | ||
| Q2 25 | -23.3% | -0.6% | ||
| Q1 25 | -36.1% | -5.4% | ||
| Q4 24 | 5.2% | -0.4% | ||
| Q3 24 | -8.2% | -1.2% | ||
| Q2 24 | -18.3% | -0.5% | ||
| Q1 24 | -23.9% | -9.0% |
净利率CTKBSTRR
| Q4 25 | -70.9% | -3.0% | ||
| Q3 25 | -10.5% | -3.7% | ||
| Q2 25 | -12.2% | -1.9% | ||
| Q1 25 | -27.5% | -5.5% | ||
| Q4 24 | 16.8% | -1.7% | ||
| Q3 24 | 1.8% | -2.3% | ||
| Q2 24 | -22.4% | -1.2% | ||
| Q1 24 | -13.8% | -8.6% |
每股收益（稀释后）CTKBSTRR
| Q4 25 | — | $-0.49 | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.59 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | — | $-0.28 | ||
| Q2 24 | — | $-0.15 | ||
| Q1 24 | — | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $65.7M |
| 总资产 | $461.5M | $113.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBSTRR
| Q4 25 | $90.9M | $10.3M | ||
| Q3 25 | $93.3M | $15.4M | ||
| Q2 25 | $75.5M | $16.8M | ||
| Q1 25 | $95.3M | $16.6M | ||
| Q4 24 | $98.7M | $17.0M | ||
| Q3 24 | $162.3M | $15.8M | ||
| Q2 24 | $177.9M | $14.7M | ||
| Q1 24 | $168.8M | $20.4M |
总债务CTKBSTRR
| Q4 25 | — | — | ||
| Q3 25 | — | $6.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CTKBSTRR
| Q4 25 | $341.7M | $65.7M | ||
| Q3 25 | $378.6M | $67.8M | ||
| Q2 25 | $377.6M | $40.1M | ||
| Q1 25 | $379.6M | $39.5M | ||
| Q4 24 | $395.7M | $40.4M | ||
| Q3 24 | $385.5M | $42.9M | ||
| Q2 24 | $389.1M | $42.6M | ||
| Q1 24 | $392.6M | $44.3M |
总资产CTKBSTRR
| Q4 25 | $461.5M | $113.2M | ||
| Q3 25 | $494.9M | $117.1M | ||
| Q2 25 | $493.3M | $55.6M | ||
| Q1 25 | $482.6M | $53.2M | ||
| Q4 24 | $499.5M | $52.6M | ||
| Q3 24 | $491.2M | $52.6M | ||
| Q2 24 | $483.7M | $52.6M | ||
| Q1 24 | $492.1M | $52.6M |
负债/权益比CTKBSTRR
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $-7.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $-9.0M |
| 自由现金流率自由现金流/营收 | -2.9% | -15.8% |
| 资本支出强度资本支出/营收 | 1.6% | 3.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $-13.0M |
8季度趋势，按日历期对齐
经营现金流CTKBSTRR
| Q4 25 | $-771.0K | $-7.3M | ||
| Q3 25 | $-3.9M | $-2.7M | ||
| Q2 25 | $108.0K | $139.0K | ||
| Q1 25 | $-125.0K | $-802.0K | ||
| Q4 24 | $2.0M | $-2.8M | ||
| Q3 24 | $13.2M | $1.3M | ||
| Q2 24 | $6.2M | $-4.3M | ||
| Q1 24 | $4.0M | $-1.8M |
自由现金流CTKBSTRR
| Q4 25 | $-1.8M | $-9.0M | ||
| Q3 25 | $-4.6M | $-3.4M | ||
| Q2 25 | $-1.5M | $102.0K | ||
| Q1 25 | $-974.0K | $-808.0K | ||
| Q4 24 | $1.1M | $-2.8M | ||
| Q3 24 | $12.2M | $1.3M | ||
| Q2 24 | $5.2M | $-4.3M | ||
| Q1 24 | $3.4M | $-1.8M |
自由现金流率CTKBSTRR
| Q4 25 | -2.9% | -15.8% | ||
| Q3 25 | -8.7% | -7.0% | ||
| Q2 25 | -3.2% | 0.3% | ||
| Q1 25 | -2.3% | -2.5% | ||
| Q4 24 | 1.9% | -8.3% | ||
| Q3 24 | 23.7% | 3.4% | ||
| Q2 24 | 11.0% | -12.0% | ||
| Q1 24 | 7.6% | -5.3% |
资本支出强度CTKBSTRR
| Q4 25 | 1.6% | 3.0% | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.0% | ||
| Q1 24 | 1.3% | 0.0% |
现金转化率CTKBSTRR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
STRR
| Revenue From Other Contracts With Customers | $27.6M | 49% |
| Other | $24.3M | 43% |
| Energy Services Segment | $4.9M | 9% |
